Search clinical trials for: Yersinia F1 antigen

Total 2226 results

Kinki University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer

Gastric Cancer

Japan
Kinki University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer

Esophageal Cancer

Japan
GlaxoSmithKline

Completed

ARTS - AVODART After Radical Therapy For Prostate Cancer Study (ARTS)

Neoplasms, Prostate | Prostate Cancer After a Radical Treatment

Spain, Estonia, Netherlands, United Kingdom, Germany, Finland, France, Russian Federation, Sweden
Roll International Corporation

Unknown

Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer

Prostate Cancer

United States
Roll International Corporation

Unknown

Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer

Prostate Cancer

United States
Ferring Pharmaceuticals

Terminated

The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"

Crohn's Disease

Sweden
Novartis Pharmaceuticals

Completed

Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Hepatitis B Virus

China
Albert B. Sabin Vaccine Institute

Completed

Development of a Skin Test for the Na-ASP-2 Hookworm Antigen

Allergy | Hookworm Infection

United States
Children's Hospital Medical Center, Cincinnati
United States Department of Defense

Completed

Susceptibility of Human Volunteers With Different Histo-Blood With Different Histo-Blood Group Antigens to Norovirus

Healthy Adults

United States
Tuberculosis Clinical Diagnostics Research Consortium
Makerere University

Unknown

Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis

Tuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Miliary

Uganda
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects

Influenza

Italy
University of Colorado, Denver

Completed

A Pragmatic Trial of the Effect of a Mailed Patient Flyer About Prostate Specific Antigen (PSA) Testing Prior to an Annual Exam

Prostate Cancer Screening

United States
Jules Bordet Institute

Unknown

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia (ASCI)

Effects of Immunotherapy | Acute Myelogenous Leukemia | Myeloid Leukemia in Remission

Belgium
Memorial Sloan Kettering Cancer Center
PSMA Development Corp, LLC

Completed

Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel

Prostate Cancer

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects

Influenza

United Kingdom
Novartis Vaccines

Completed

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age

Invasive Group B Streptococcus (GBS) Disease

Switzerland
Novartis Vaccines

Completed

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age

Invasive Group B Streptococcus (GBS) Disease

Switzerland
DynPort Vaccine Company LLC, A GDIT Company

Completed

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

Healthy Volunteers

United States
Inge Marie Svane

Completed

Dendritic Cell Based Therapy of Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

Denmark
Tehran University of Medical Sciences

Completed

Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients

Renal Failure
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
St Stephens Aids Trust

Terminated

Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens

HIV Infections

United Kingdom
FHI 360
La Asociación Pro Bienestar de la Familia de Guatemala (APROFAM)

Completed

Continuous Use of COCs

Pregnancy Prevention

Dominican Republic, Nicaragua
Seagen Inc.

Completed

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

Prostatic Neoplasms

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects

Influenza

Germany
Seagen Inc.

Completed

A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndrome (MDS)

United States
Universidad de Antioquia
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) and other collaborators

Completed

Lovastatin: Immunomodulatory Value Evaluation (LIVE)

HIV Seropositivity

Colombia
University of Florida

Completed

Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer

Biochemical Recurrent Prostate Cancer

United States
Roll International Corporation
National Cancer Institute (NCI)

Completed

Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer

Prostate Cancer
FHI 360
Muhimbili University of Health and Allied Sciences

Completed

Integration of Family Planning and HIV Services in Tanzania

HIV Infections | HIV Infection

Tanzania
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Terminated

Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreas Neoplasms

Japan
Novartis

Terminated

Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)

Hepatitis B

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

Pneumonic Plague | Preventive Therapy

United States
NorthShore University HealthSystem
Northwestern University; Genentech, Inc.

Completed

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

Prostate Cancer

United States
Mayo Clinic
Paul E. Evans MD; William J. Sandborn MD; Edward V. Loftus MD; Thomas C. Smryk MD; Willaim Tremaine...

Completed

Trial of Mesalamine for the Treatment of Active Microscopic Colitis

Diarrhea | Microscopic Colitis

United States
Seoul National University Hospital

Completed

Aggressive Prostate Cancers in Elderly Patients

Prostatic Neoplasms

Korea, Republic of
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH); Rockefeller...

Completed

Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy

Melanoma

United States
Bristol-Myers Squibb

Completed

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

Chronic Hepatitis B

United States
Bristol-Myers Squibb

Completed

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

Chronic Hepatitis B

United States
Hadassah Medical Organization

Withdrawn

Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host

Neoplasm Metastasis | Hematological Malignancy

Israel
Ann & Robert H Lurie Children's Hospital of Chicago

Unknown

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

Lymphoma, Malignant | Leukemia, Myelogenous, Chronic | Leukemia, Lymphoblastic, Acute | Leukemia, Myelogenous, Acute | Myeloproliferative-Myelodysplastic Diseases

United States
University of Oxford

Completed

A Study of AdCh63 AMA1 Alone and With MVA AMA1

Malaria

United Kingdom
National Institute of Allergy and Infectious Diseases...
Biogen

Terminated

A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)

HIV Infections

United States
Roswell Park Cancer Institute

Completed

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Lung Cancer | Malignant Mesothelioma

United States
Radboud University Medical Center
London School of Hygiene and Tropical Medicine; Imperial College London; University... and other collaborators

Completed

Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires

Malaria | Schistosomiasis | Hiv Infection

Uganda
National Institute of Allergy and Infectious Diseases...

Completed

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

HIV Infections

United States, Australia
Quantum Immunologics, Inc.
University of South Alabama

Unknown

Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer

Breast Cancer

United States
National Taiwan University Hospital

Unknown

Diagnosis of Invasive Pulmonary Aspergillosis by Direct Lung Tissue Aspergillus Galactomannan Antigen Detection From Aspirate by Ultrasound-guided Fine Needle Aspiration

Immunocompromised

Taiwan
St George's, University of London
European Union

Completed

Measuring Responses to Sublingual Antigens

Sexually Transmitted Diseases, Viral

United Kingdom
Pfizer

Completed

Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder

Major Depressive Disorder

3

Subscribe